ENZYTEC
LIVE

Serial Number

79070925

Owner

R-Biopharm AG

Attorney

Maury M. Tepper, III

Filing Date

May 7, 2009

Add to watchlist:

No watchlists yet
View on USPTO

ENZYTEC Trademark

Serial Number: 79070925 • Registration: 3896524

ENZYTEC is a trademark filed by R-Biopharm AG on May 7, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

R-Biopharm AG (15 trademarks)

An der neuen Bergstrasse 17

Entity Type: 98

Trademark Details

Filing Date

May 7, 2009

Registration Date

December 28, 2010

Published for Opposition

May 11, 2010

Goods & Services

[ reagents for medical purposes only and not in the fields of allergies, uppermost in connection with respiratory conditions, decongestants and antihistamines ]

Chemicals for use in science; chemical reagents for laboratory use for non-medical purposes; chemical research reagents for industrial use, namely, for testing food chemistry

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 11, 2023 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 18, 2022 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 5, 2021 INPR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 13, 2021 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
May 10, 2021 CRCV
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 6, 2021 NA71
REGISTERED-SEC.71 ACCEPTED
Apr 5, 2021 71AG
TEAS SECTION 71 RECEIVED
Dec 14, 2020 ES71
NEW REPRESENTATIVE AT IB RECEIVED
May 1, 2020 NREP
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Dec 28, 2019 REM4
INTERNATIONAL REGISTRATION RENEWED
May 23, 2019 RNWL
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 14, 2019 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Mar 29, 2019 LIMG
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jan 30, 2018 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 22, 2018 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 22, 2017 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
May 22, 2017 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 22, 2017 APRE
TEAS SECTION 71 & 15 RECEIVED
Dec 28, 2016 ES75
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 3, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 3, 2016 REAP
NEW REPRESENTATIVE AT IB RECEIVED
May 15, 2015 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Mar 12, 2015 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 24, 2013 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 18, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 27, 2011 FICS
FINAL DISPOSITION PROCESSED
Apr 27, 2011 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 28, 2011 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Jan 28, 2011 NREP
REGISTERED-PRINCIPAL REGISTER
Dec 28, 2010 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 23, 2010 ETOP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Sep 24, 2010 LIME
EXTENSION OF TIME TO OPPOSE RECEIVED
May 31, 2010 ETOF
PUBLISHED FOR OPPOSITION
May 11, 2010 PUBO
LIMITATION OF GOODS RECEIVED FROM IB
Apr 22, 2010 LIMG
NOTICE OF PUBLICATION
Apr 21, 2010 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 7, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2010 CNSA
AMENDMENT FROM APPLICANT ENTERED
Mar 18, 2010 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2010 CRFA
ASSIGNED TO LIE
Mar 18, 2010 ALIE
PAPER RECEIVED
Mar 8, 2010 MAIL
FAX RECEIVED
Mar 3, 2010 FAXX
NON-FINAL ACTION MAILED
Feb 16, 2010 CNRT
NON-FINAL ACTION WRITTEN
Feb 15, 2010 CNRT
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Jan 7, 2010 LIMS
LIMITATION OF GOODS RECEIVED FROM IB
Dec 11, 2009 LIMG
REFUSAL PROCESSED BY IB
Sep 29, 2009 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 21, 2009 RFCS
REFUSAL PROCESSED BY MPU
Aug 21, 2009 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 21, 2009 RFCR
NON-FINAL ACTION WRITTEN
Aug 20, 2009 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 18, 2009 MAFR
ASSIGNED TO EXAMINER
Aug 14, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2009 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 13, 2009 REPR